Abstract
Vaccines are a natural focal point for Marek’s disease (MD) as they pose challenging questions regarding their mechanism of action and constitute the main means by which the disease can be controlled. The first practical vaccine for MD was developed by Churchill et al. (1) and consisted of an attenuated serotype 1 MD virus (MDV). This development followed shortly the isolation of the causative herpesvirus of MD and its propagation in tissue culture. Several other vaccines were subsequently developed. Probably turkey herpesvirus, a serotype 3 virus, is the most widely used of the vaccine types at present.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Churchill AE, Payne LN, Chubb RC: Immunization against Marek’s disease using a live attenuated virus. Nature (221): 744–747, 1969.
Lee LF, Liu S, Witter RL: Monoclonal antibodies with specificity for 3 different serotypes of Marek’s disease viruses in chickens. J Imnunol (130): 1003–1006, 1983.
Spencer JL, Robertson A: Influence of maternal antibody on infection with virulent or attenuated Marek’s disease herpesvirus. Am J Vet Res (33): 393–400, 1972.
Eidson CS, Anderson DP, King DD: Resistance of progeny from parental stock of chickens immunized against Marek’s disease. Am J Vet Res (32): 2071–2076, 1971.
Nazerian K: Attenuation of Marek’s disease virus and study of its properties in two different cell cultures. J Natl Cancer Inst (44): 1257–1267, 1970.
Jackson CAW, Sinkovic B, Choi CO: Infectivity and imnunogenicity of apathogenic and attenuated Marek’s disease virus vaccines. Proc 54th Ann Conf Australian Vet Assoc, 1977, pp 149–152.
Willemart JP: Marek’s disease. Study on the efficacy of three vaccines. Recl Med Vet (148): 203–216, 1972.
Rispens BH, Van Vloten H, Maas HJ, Hendrick JL: Control of Marek’s disease in The Netherlands. I. Isolation of an avirulent Marek’s disease virus strain (CVI 988) and its use in laboratory vaccination trials. Avian Dis (16): 108–125, 1972.
Rispens BH, Van Vloten H, Mastenbroek N, Maas HJ, Hendrik JL: Control of Marek’s disease in The Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek’s disease virus. Avian Dis (16): 126–138, 1972.
Bülow V von: Further characterisation of the CVI 988 strain of Marek’s disease virus. Avian Pathol (6): 395–403, 1977.
Maas HJL, Rispens BH, Heuff A, Groenendal JE: Results of vaccination of Marek’s disease of broiler breeders. Landbouwkundig Tijdschrift (85): 147–163, 1973.
Maas HJL, Borm F, Kieft G van de: The prevention of Marek’s disease in Holland by vaccination with cell-associated vaccines. World’s Poult Sci J (38): 163–175, 1982.
Smits WH: Vaccination against Marek’s disease in The Netherlands: organization and results. Proc XX World Vet Cong Thessaloniki, Greece, 1975, pp 2296–2300.
Vielitz E, Landgraf H: Vaccination experiments against Marek’s disease by application of an attenuated Marek’s herpesvirus and a turkey herpesvirus. Prog in Immunobiol Standard (5): 141–148, 1972.
Smith MW, Calnek BW: High-virulence Marek’s disease virus infection in chickens previously infected with low-virulence virus. J Natl Cancer Inst (52): 1595–1603, 1974.
Witter RL: Protection by attenuated and polyvalent vaccines against highly virulent strain of Marek’s disease virus. Avian Pathol (11): 49–62, 1982.
Witter RL, Lee LF: Polyvalent Marek’s disease vaccines: Safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathol (13): 75–92, 1984.
Witter RL, Sharma JM, Lee LF, Optiz HM, Henry CW: Field trials to test the efficacy of polyvalent Marek’s disease vaccines in broilers. Avian Dis (28): 44–60, 1984.
Zander DV, Hill RW, Raymond RG, Balch RK: The use of blood from selected chickens as an immunizing agent for Marek’s disease. Avian Dis (16): 163–178, 1972.
Cho BR, Kenzy SG: Isolation and characterization of an isolate (HN) of Marek’s disease virus with low pathogenicity. Appl Microbial (24): 299–306, 1972.
Biggs PM, Powell DG, Churchill AE, Chubb RC: The epizootiology of Marek’s disease. 1. Incidence of antibody, viraemia and Marek’s disease in six flocks. Avian Pathol (1): 5–26, 1972.
Biggs PM, Jackson CAW, Powell DG: The epizootiology of Marek’s disease. 2. The effect of supply flock, rearing house, and production house on the incidence of Marek’s disease. Avian Pathol (2): 127–134, 1973.
Schat KA, Calnek BW: Characterization of an apparently non- oncogenic Marek’s disease virus. J Natl Cancer Inst (60):1075–1082, 1978.
Kawamura H, King DJ, Anderson DP: A herpesvirus isolated from kidney cell culture of normal turkeys. Avian Dis (13): 853–863, 1969.
Witter RL, Nazerian K, Purchase HG, Burgoyne GH: Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek’s disease virus. Am J Vet Res (31): 525–538, 1970.
Witter RL, Solomon JJ: Epidemiology of a herpesvirus of turkeys: possible sources and spread of infection in turkey flocks. Infect Immun (4): 356, 1971.
Zygraich N, Huygelen C: Inoculation of one-day-old chicks with different strains of turkey herpesvirus. II. Virus replication in tissues of inoculated animals. Avian Dis (16): 793–798, 1972.
Cho BR: Horizontal transmission of turkey herpesvirus to chickens. IV. Viral maturation in the feather follicle epithelium. Avian Dis (19): 136–141, 1975.
Cho BR: Horizontal transmission of turkey herpesvirus to chickens. 5. Airborne transmission between chickens. Poult Sci (55): 1830–1833, 1976.
Okazaki W, Purchase HG, Burmester BR: Protection against Marek’s disease by vaccination with a herpevirus of turkeys. Avian Dis (14): 413–429, 1970.
Purchase HG, Okazaki W, Burmester BR: Field trials with the herpesvirus of turkeys (HVT) strain FC126 as a vaccine against Marek’s disease. Poult Sci (50): 775–783, 1971.
Purchase HG, Okazaki W, Burmester BR: Long-term field trials with the herpesvirus of turkeys vaccine against Marek’s disease. Avian Dis (16): 57–71, 1972.
Churchill AE, Baxendale W, Carrington G: Viraemia and antibody development in chicks following the administration of turkey herpesvirus. Vet Rec (92): 327–333, 1973.
Zygraich N, Huygelen C: Inoculation of one-day-old chicks with different strains of turkey herpesvirus. I. Serological studies. Avian Dis (16): 735–740, 1972.
Jackson CAW, Webster AC, Van Der Kooi K, Sheridan AK, Sinkovic B: Field trials of herpesvirus of turkeys N S W 1/70 vaccine against Marek’s disease. Proc 1974 Australian Poult Sci Con, Hobart, Tasmania, 1974, pp 238–241.
Calnek BW, Hitchner SB, Adldinger HK: Lyophilization of cell-free Marek’s disease herpesvirus and a herpesvirus from turkeys. Appl Microbial (20): 723–726, 1970.
Calnek BW, Schat KA, Peckham MC, Fabricant J: Field trials with a bivalent vaccine (HVP and SB-1) against Marek’s disease. Avian Dis (27): 844–849, 1983.
Stephens EA, Witter RL, Lee LF, Sharma JM, Nazerian K, Longenecker BM: Characteristics of JMV Marek’s disease tumor: A nonproductively infected transplantable cell lacking in rescuable virus. J Natl Cancer Inst (57): 865–874, 1976.
Shieh HK, Sevoian M: Antibody response to genetically susceptible and resistant chickens to cell-free and attenuated JM-V leukosis strain and its influence on early type II (Marek’s) leukosis infection. Poult Sci (54): 69–77, 1975.
Munch D, Sevoian M: Growth and characterization of, and immunological response of chickens to, a cell line established fran JMV lymphoblastic leukemia. Avian Dis (24): 23–36, 1980.
Bülow V von: Cross-protection between JMV Marek’s disease-derived tumour transplant, Marek’s disease and turkey herpesvirus. Avian Pathol (6): 353–366, 1977.
Nazerian K, Witter RL: Immunization against Marek’s disease transplantable cell lines. Avian Dis (28): 160–167, 1984.
Landgraf H, Vielitz E: Potency tests with HVT-, MHV- and JMV vaccines against Marek’s disease. Avian Pathol (7): 193–202, 1978.
Kaaden OR, Dietzschold B, Ueherschar S: Vaccination against Marek’s disease: Immunizing effect of purified turkey herpes virus and cellular membranes from infected cells. Med Microbial Immunol (159): 261–269, 1974.
Powell PC: Impunity to Marek’s disease induced by glutaraldehydetreated cells of Marek’s disease lyhoblastoid cell lines. Nature (257): 684–685, 1975.
Powell PC, Rowell JG: Dissociation of antiviral and antitumor immunity in resistance to Marek’s disease. J Natl Cancer Inst (59): 919–924, 1977.
Murthy KK, Calnek BW: Pathogenesis of Marek’s disease: Effect of immunization with inactivated viral and tumor-associated antigens. Infect Immun (26): 547–553, 1979.
Lesnik F, Ross LJN: Immunization against Marek’s disease using Marek’s disease virus-specific antigens free from infectious virus. Int J Cancer (16): 153–163, 1975.
Kaaden OR: Induction of virus-neutralising antibodies and partial immunity in chickens by a polysomal fraction prepared from turkey herpesvirus-infected cells. In: Biggs PM (ed) Resistance and Immunity to Marek’s disease. CEC Publication EUR 6470, Luxembourg, 1980, pp 278–284.
Wyn-Jones AP, Kaaden OR: Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys. Infect Immun (25): 54–59, 1979.
Lesnik F, Chudy D, Vrtiak OJ, Konrad V, Danibel M, Ragac P, Polacek M: Immunization trials with virus-free antigens against Marek’s disease. Comp Inmunol Microbiol Infect Dis (2): 491–500, 1980.
Prasad LBM, Spradbrow PB: Ultrastructure and infectivity of tissues from normal and inmunodepressed chickens inoculated with turkey herpesvirus. J Camp Pathol (90): 47–56, 1980.
Calnek BW, Carlisle JC, Fabricant J, Murthy KK, Schat KA: Camparative pathogenesis studies with oncogenic and nononcogenic Marek’s disease viruses and turkey herpesvirus. Am J Vet Res (40): 541–548, 1979.
Phillips PA, Biggs PM: Course of infection in tissue of susceptible chickens after exposure to strains of Marek’s disease and turkey herpesvirus. J Natl Cancer Inst (49): 1367–1373, 1972.
Witter RL, Sharma JM, Offenbecker L: Turkey herpesvirus infection in chickens: Induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek’s disease. Avian Dis (20): 676–692, 1976.
Witter RL, Offenbecker L: Duration of vaccinal immunity against Marek’s disease. Avian Dis (22): 396–408, 1978.
Sharma JM, Burmester BR: Resistance to Marek’s disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis (26): 134–149, 1982.
Sharma JM: Effect of infectious bursal disease virus on protection by Marek’s disease vaccine. Avian Dis (28): 629–640, 1984.
Witter RL, Solomon JJ, Champion LR, Nazerian K: Long term studies of Marek’s disease infection in individual chickens. Avian Dis (15): 346–365, 1971.
Witter RL, Offenbecker L: Nonprotective and temperature-sensitive variants of Marek’s disease vaccine viruses. J Natl Cancer Inst (62): 143–151, 1979.
Thornton DH, Hinton MH, Muskett JC: Efficacy of Marek’s disease vaccines; protection and viraemia studies with turkey herpesvirus vaccines. Avian Pathol (4): 97–108, 1975.
Cho BR: Studies of turkey herpesvirus viremia in two strains of vaccinated chickens: Strain difference and effects of vaccine dose. Avian Dis (21): 394–401, 1977.
Sharma JM, Lee LF, Witter RL: Effect of neonatal thymectomy on pathogenesis of herpesvirus of turkeys in chickens. Am J Vet Res (40): 761–764, 1980.
Patrascu IV, Calnek BW, Smith MW: Vaccination with lyophilized turkey herpesvirus (HVT): minimum infective and protective doses. Avian Dis (19): 89–93, 1972.
Purchase HG, Okazaki W, Burmester BR: The minimum protective dose of the herpesvirus of turkeys vaccine against Marek’s disease. Vet Rec (91): 79–83, 1972.
Witter RL, Burmester BR: Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek’s disease vaccines. Avian Pathol (8): 145–156, 1979.
Fabricant J, Calnek BW, Schat KA: The early pathogenesis of turkey herpesvirus infection in chickens and turkeys. Avian Dis (926): 257–264, 1982.
Shek WR, Schat KA, Calnek BW: Characterization of non-oncogenic Marek’s disease virus-infected and turkey herpesvirus-infected lymphocytes. J Gen Virol (63): 333–341, 1982.
Calnek BW, Shek WR, Schat KA: Latent infections with Marek’s disease virus and turkey herpesvirus. J Natl Cancer Inst (66): 585–590, 1981.
Cho BR, Kenzy SG, Haider SA: Horizontal transmission of turkey herpesvirus to chickens. I. Preliminary observations. Poult Sci (50): 881–887, 1971.
Nazerian K, Witter RL: Cell-free transmission and in vivo replication of Marek’s disease virus (MDV). J Virol (5): 388–397, 1970.
Cho BR, Kenzy SG: Dual infection of chickens with acute and mild strains of Marek’s disease herpesvirus. Avian Dis (17): 390–395, 1973.
Cho BR: Dual virus maturation of both pathogenic and apathogenic Marek’s disease herpesvirus (MDHV) in the feather follicles of dually infected chickens. Avian Dis (21): 501–507, 1977.
Dobos-Kovacs M, Kardevan A, Zejer J: Endophthalmitis (Uveitis) in poultry flocks repeatedly immunized against Marek’s disease. Magy Allatory Lap (37): 675–683, 1982.
Henderson BW, Gardner MB, Charman HP, Johnson EY, Rucio T, Sarman PS, Alena B, Heubner RJ: Investigation of an increase of solid tumors in chickens vaccinated against Marek’s disease. Avian Dis (18): 58–66, 1974.
de Boer GF, van Vioten J, van Zaane D: Possible horizontal spread of lymphoid leukosis virus during vaccination against Marek’s disease. In: Biggs PM (ed): Resistance and Impunity to Marek’s Disease, CEC Publication, EUR 6470, Luxembourg, 1980, pp 552–565.
Fletcher OJ, Eidson CS, Kleven SH: Bursal lesions in chickens inoculated with Marek’s disease vaccines. Avian Dis (16): 153–162, 1972.
Gohda M, Yoshimura S, Odagiri Y: Pathology of turkey herpesvirus infection in chick embryos. J Jpn Vet Med Assoc (28): 417–420, 1975.
Calnek BW, Schat KA, Fabricant J: Modification of Marek’s disease pathogenesis by in ovo infection or prior vaccination. In: Viruses in Naturally Occurring Cancers. Cold Spring Harbor Conferences on Cell Proliferation (7):185–197, 1980.
Schat KA, Calnek BW: Demonstration of Marek’s disease tumor associated surface antigen in chickens infected with nononcogenic Marek’s disease virus and herpesvirus of turkeys. J Natl Cancer Inst (61): 855–858, 1978.
Powell PC, Rennie M: Marek’s disease tumour specific antigen induced by the herpesvirus of turkeys in vaccinated chickens. Vet Rec (103): 232–233, 1978.
Kitamoto N, Ikuta L, Kato S, Wataki K: Demonstration of cells with Marek’s disease tumor-associated surface antigen in chicks infected with herpesvirus of turkeys, 01 strain. Biken J (22): 137–142, 1979.
Box PG, Furminger IGS, Warden D: Immunization against Newcastle disease in the presence of Marek’s disease virus. Vet Rec (89): 475–478, 1971.
Yamada S, Uchinuno Y, Koda Y, Tokiyoshi S, Fujikawa H: Causes of death and antibody responses of chickens to several pathogens in the presence of herpesvirus of turkeys. J Jpn Vet Med Assoc (27): 14–19, 1974.
Ellis MN, Eidson CS, Brown J, Fletcher OJ, Kleven SH: Serological responses to Mycoplasma synoviae in chickens infected with virulent or avirulent strains of Marek’s disease virus. Poult Sci (60): 1344–1347, 1981.
Sharma JM, Lee LF, Wakenell PS: Capparative viral, immunologic and pathologic responses to turkey herpesvirus (HVP) of chickens inoculated as embryos or at hatch. Am J Vet Res (45): 1619–1623, 1984.
Lee LF, Sharma JM, Nazerian K, Witter RL: Suppression and enhancement of mitogen response in chickens infected with Marek’s disease virus and the herpesvirus of turkeys. Infect Immun (21): 474–479, 1978.
Schat KA, Schultz RD, Calnek BW: Marek’s disease: Effect of virus pathogenicity and genetic susceptibility on response of peripheral blood lymphocytes to concanavalin-A. Advances in Comparative Leukemia Research, Proc 8th Int Sym, 1978, pp 183–186.
Powell PC: In vitro stimulation of blood lymphocytes by phytohaemagglutinin during the development of Marek’s disease. Avian Pathol (9):471–475, 1980.
Benda V, Vilhelmova M, Hala K: Stimulation of chicken spleen cell mitogenic response with turkey herpesvirus vaccine against Marek’s disease (PHA stimulation). Folia Biol (Praha) (24): 211–214, 1978.
Melchior FW Jr., Fredrickson TN, Luginbuhl RE: Neutralization studies with Marek’s disease virus and turkey herpesvirus. Appl Microbiol (26): 925–933, 1973.
Calnek BW: Antibody development in chickens exposed to Marek’s disease virus. In: Biggs PM, de Thé G, Payne LN (eds) Oncogenesis and Herpesvirus. IARC Scientific Publications No 2, International Agency for Research on Cancer, Lyon, 1972, pp 129–137.
Billow V von, Biggs PM: Differentiation between strains of Marek’s disease virus and turkey herpesvirus by immunofluorescence assays. Avian Pathol (4): 146–147, 1975.
Billow V von, Biggs PM: Precipitating antigens associated with Marek’s disease viruses and a herpesvirus of turkeys. Avian Pathol (4): 147–162, 1975.
Witter RL, Stephen EA, Sharma JM, Nazerian K: Demonstration of a tumor-associated surface antigen in Marek’s disease. J Imnunol (115): 177–188, 1975.
Stephens EA, Witter RL, Nazerian K, Sharma JM: Development and characterization of a Marek’s disease transplantable tumor in inbred line 72 chickens homozygous at the major (B) histocompatibility locus. Avian Dis (24): 358–374, 1980.
Spencer JL, Gavora JS: Influence of genotype of chickens and immune status of dams on response to vaccination with turkey herpesvirus. In: Biggs PM (ed) Resistance and Immunity to Marek’s disease, CEC Publication EUR 6470, Luxembourg, 1980, pp 519–537.
Burgoyne GH, Witter RL: Effect of passively transferred immunoglobulins on Marek’s disease. Avian Dis (17): 824–837, 1973.
Kotlama H, Sugimoto C, Inage F, Mikami T: Anti-viral immunity against Marek’s disease virus infected chicken kidney cells. Avian Pathol (8): 33–44, 1979.
Patrascu IV, Calnek BW: In vitro assay of cell-free turkey herpesvirus. Avian Dis (16): 397–412, 1972.
Prasad LBM: Induction of delayed hypersensitivity to turkey herpesvirus in fowls. Res Vet Sci (25): 258–259, 1978.
Ross, LJN: Antiviral T cell-mediated immunity in Marek’s disease. Nature (266): 644–646, 1977.
Ross LJN: Mechanism of protection conferred by HVT. In: Biggs PM (ed) Resistance and Immunity to Marek’s Disease, CEC Publication EUR 6470, Luxembourg, 1980, pp 289–297.
Powell PC: Studies on Marek’s disease lymphoma-derived cell lines. Bibliotheca Haematologica (43): 348–350, 1976.
Sharma JM: Role of tumor antigen in vaccine protection in Marek’s disease. Advances in Experimental Medicine and Biology, Vol. 88, Avian Immunology: 345–353, 1977.
Sharma J, Witter RL, Coulson BD: Development of cell-mediated impunity to Marek’s disease tumor cells in chickens inoculated with Marek’s disease vaccines. J Natl Cancer Inst (61): 1273–1280, 1978.
Kitamoto N, Ikuta K, Kato S, Yamaguchi S: Cell-mediated cytotoxicity of lymphocytes from chickens inoculated with herpesvirus of turkey against a Marek’s disease lymphoma cell line (MSB-1). Biken J (22): 11–20, 1979.
Confer AW, Adldinger HK: Cell-mediated immunity in Marek’s disease: Cytotoxic responses in resistant and susceptible chickens and relation to disease. Am J Vet Res (41): 307–312, 1980.
Dambrine G, Coudert F, Cauchy L: Cell-mediated cytotoxicity in chickens infected with Marek’s disease virus and the herpesvirus of turkeys. In: Biggs PM (ed) Resistance and Impunity to Marek’s Disease, CEC Publication EUR 6470, Luxembourg, 1980, pp 320–337.
Sugimoto C, Kodamm H, Mikami T: Anti-tumor immunity against Marek’s disease-derived lymphoblastoid cell line (MSB-1). Jap J Vet Res (26): 57–67, 1978.
Schat KA, Shek WR, Calnek BW, Abplanalp H: Syngeneic and allogeneic cell-mediated cytotoxicity against Marek’s disease lymphoblastoid tumor cell lines. Int J Cancer (29): 187–194, 1982.
Powell PC, Mustill BM, Rennie M: The role of histocompatibility antigens in cell-mediated cytotoxicity against Marek’s disease tumour-derived lymphoblastoid cell lines. Avian Pathol (12):461–468, 1983.
Donahoe J, Kleven S, Eidson C: Resistance to Marek’s disease. Effect of Corynebacterium parvum and Marek’s tumor cell vaccines on tumorigenesis in chickens. J Natl Cancer Inst (60): 829–833, 1978.
Mason RJ, Jensen KE: Marek’s disease: Resistance of turkey herpesvirus-infected chicks against lethal JM -V agent. Am J Vet Res (32): 1625–1627, 1971.
Sevoian M, Weston CR: The effects of JM and JM-V leukosis strains on chicks vaccinated with herpes virus of turkeys (HVT). Poult Sci (51): 513–516, 1972.
Spencer JL, Gavora JS, Hare WCD, Grunder AA, Robertson A, Speckmann GW: Studies on genetic and vaccination-induced resistance of chickens to lymphoid tumor transplants. 1. Marek’s disease tumor transplant (JMV). Avian Dis (20): 268–285, 1976.
Schat KA, Calnek BW: Protection against Marek’s disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek’s disease virus. Infect Immun (22): 225–232, 1978.
Schierman LW, McBride, RA: Effects of vaccination for Marek’s disease on growth of a Marek’s-virus-induced transplantable lymphoma in syngeneic and allogeneic chickens. Avian Dis (23): 47–56, 1979.
Powell PC, Rennie M: Failure of attenuated Marek’s disease virus and herpesvirus of turkeys antigens to protect against the JMV Marek’s disease-derived transplantable tumour. Avian Pathol (9) 193–200, 1980.
Powell PC: Protection against the JMV Marek’s disease-derived transplantable tumour by Marek’s disease virus-specific antigens. Avian Pathol (7): 305–309, 1978.
Ozaki K, Kodama H, Onuma M, Izawa H, Mikami T: In vitro suppression of proliferation of Marek’s disease lymphoma cell line (MDCC-MSB1) by peritoneal exudate cells from chickens infected with MD or HVT. Zentralbi Veterinarmed (30): 223–231, 1983.
Sharma JM: Natural killer cell activity in chickens exposed to Marek’s disease virus: Inhibition of activity in susceptible chickens and enhancement of activity in resistant and vaccinated chickens. Avian Dis (25): 882–893, 1981.
Okazaki W, Purchase HG, Burmester BR: The temporal relationship between vaccination with the herpesvirus of turkeys and challenge with virulent Marek’s disease virus. Avian Dis (15): 753–761, 1971.
Eidson CS, Anderson DP: Optimum age for vaccinating chickens against Marek’s disease. Poult Sci (50): 1837–1841, 1971.
Basarab O, Hall T: Comparisons of cell-free and cell-associated Marek’s disease vaccines in maternally immune chicks. Vet Rec (99): 4–6, 1976.
Cho BR, Balch RK, Hill RW: Marek’s disease vaccine breaks: Differences in viremia of vaccinated chickens between those with and without Marek’s disease. Avian Dis (20): 496–503, 1976.
Riddell C, Milne BS, Biggs PM: Herpesvirus of turkey vaccine: viraemias in field flocks and in experimental chickens. Vet Rec (102): 123–125, 1978.
Okazaki W, Purchase HG, Burmester BR: Vaccination against Marek’s disease: Possible causes of failure of herpesvirus of turkeys (Strain FC126) to protect chickens against Marek’s disease. Am J Vet Res (34): 813–817, 1973.
Schierman LW, Theis GA, McBride RA: Preservation of a thymus derived cell-mediated immune repsonse in Marek’s disease virus infected chickens by vaccination with a related virus. J Imnunol (116): 1497–1499, 1976.
Purchase HG, Okazaki W: Effect of vaccination with herpesvirus of turkeys (HVT) on horizontal spread of Marek’s disease herpesvirus. Avian Dis (15): 391–397, 1971.
Eidson CS, Fletcher OJ, Kleven SH, Anderson DP: Detection of Marek’s disease antigen in feather follicle epithelium of chickens vaccinated against Marek’s disease. J Natl Cancer Inst (47):113–120, 1971.
Payne LN, Roszkowski J: The presence of immunologically uncommitted bursa and thymus dependent lymphoid cells in the lymphomas of Marek’s disease. Avian Pathol (1): 27–34, 1972.
Schat KA, Calnek BW, Fabricant J: Characterization of two highly oncogenic strains of Marek’s disease virus. Avian Pathol (11): 593–606, 1982.
Payne LN, Frazier JA, Powell PC: Pathogenesis of Marek’s disease. Int Rev Exp Pathol (16): 59–154, 1976.
Payne LN: Biology of Marek’s disease virus and the herpesvirus of turkeys. In: Roizman B (ed) The Herpesvirus, Vol. 1. Plenum Press, New York and London, 1982, pp 347–431.
Purchase HG, Sharma JM: Amelioration of Marek’s disease and absence of vaccine protection in immunologically deficient chickens. Nature (248): 419–421, 1974.
Payne LN, Rennie MC, Powell PC, Rowell JG: Transient effect of cyclophosphamide on vaccinal immunity to Marek’s disease. Avian Pathol (7): 295–304, 1978.
Gupta SK, Kharole MU, Kalra DS: Role of thymus-dependent immune system in HVT protection against Marek’s disease. Avian Dis (26): 7–13, 1982.
Else, RW: Vaccinal immunity to Marek’s disease in bursectomized chickens. Vet Rec (95): 182–187, 1974.
Rennie M, Powell PC, Mustill BM: The effect of bursectomy on vaccination against Marek’s disease with the herpesvirus of turkeys. Avian Pathol (9): 557–566, 1980.
Powell PC, Rennie M, Ross LJN, Mustill BM: The effect of bursectomiy on the adoptive transfer of resistance to Marek’s disease. Int J Cancer (26): 681–687, 1980.
Sharma JM, Coulson BD: Presence of natural killer cells in specific-pathogen-free chickens. J Natl Cancer Inst (63): 527–531, 1979.
Sharma JM: Presence of adherent cytotoxic cells and non-adherent natural killer cells in progressive and regressive Marek’s disease tumors. Vet Immunol Immunopathol (5): 125–140, 1983.
Lee LF, Sharma JM, Nazerian K, Witter RL: Suppression of mitogeninduced proliferation of normal spleen Dells by macrophages from chickens inoculated with Marek’s disease virus. J Immunol (120): 1554–1559, 1978.
Higgins DA, Calnek BW: Same effects of silica treatment on Marek’s disease. Infect Immun (13): 1054–1060, 1976.
Haffer K, Sevoian M, Wilder M: The role of the macrophage in Marek’s disease: In vitro and in vivo studies. Int J Cancer (23): 648–656, 1979.
Powell PC, Hartley KJ, Mustill BM, Rennie M: Studies on the role of macrophages in Marek’s disease of the chicken. J Reticuloend Soc (34): 289–298, 1983.
Kodama H, Mikami T, Inoue M, Izawa H: Inhibitory effects of macrophages against Marek’s disease virus plaque formation in chicken kidney cell cultures. J Natl Cancer Inst (63): 1267–1271, 1979.
Glaubiger C, Nazerian K, Velicer LF: Marek’s disease herpesvirus. IV. Molecular characterization of Marek’s disease herpesvirus A antigen. J Virol (45): 1228–1234, 1983.
Churchill AE, Chubb RC, Baxendale W: The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek’s disease (strain HPRS-16) on passage in cell culture. J Gen Virol (4): 557–564, 1969.
Kaaden OR: Marek’s disease virus-induced antigens in relation to immunity. Avian Pathol (6): 219–225, 1977.
Ikuta K, Nishi Y, Kato S, Hirai K: Imnunoprecipitation of Marek’s diseasP virus-specific polypeptides with chicken antibodies purified by affinity chromatography. Virology (114): 277–281, 1981.
van Zaane D, Brinkhof JMA, Westenbrink F, Gielkens ALJ. Molecular-biological characterization of Marek’s disease virus. I. Identification of virus-specific polypeptides in infected cells. Virology (121): 116–132, 1982.
Ikuta K, Ueda S, Kato S, Hirai K: Identification with monoclonal antibodies of glycoproteins of Marek’s disease virus and herpes-virus of turkeys related to virus neutralization. J Virol (49): 1014–1017, 1984.
Silva RF, Lee LF: Monoclonal antibody mediated inmunoprecipitation of proteins from cells infected with Marek’s disease virus or turkey herpesvirus. Virology (136): 307–320, 1984.
de Boer GF, Orthel FGW, Krasselt M, Oei HL, Pereboom WI, Barendregt LG: Comparative 50% protective dose assay (PD50) of Marek’s disease virus strain CVI988. J Biol Standard (9): 15–22, 1981.
Eidson CS, Page RK, Kleven SH: Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek’s disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek’s disease virus. Avian Dis (22): 583–597, 1978.
Ball RF, Lyman JF: Revaccination of chicks for Marek’s disease at twenty-one days old. Avian Dis (21): 440–444, 1977.
Yoshida I, Yuasa N, Tsubahara H, Horiuchi T, Ishino S: Dose effect of herpesvirus of turkeys on protection of chickens from Marek’s disease. Natl Inst Anim Health Q (Tokyo) (13): 39–44, 1973.
Witter RL, Sharma JM, Fadly AM: Pathogenicity of variant Marek’s disease virus isolants in vaccinated and unvaccinated chickens. Avian Dis (24): 210–232, 1980.
Calnek BW, Smith MW: Vaccination against Marek’s disease with cell-free turkey herpesvirus: interference by maternal antibody. Avian Dis (16): 954–957, 1972.
Eidson CS, Kleven SH, Anderson DP: Efficacy of cell-free and cell-associated herpesvirus of turkey vaccines in progeny from vaccinated parental flocks. Am J Vet Res (34): 869–872, 1973.
Spencer JL, Robertson A: Influence of vaccination with avirulent herpesvirus on subsequent infection of chickens with virulent Marek’s disease herpesvirus. Am J Vet Res (36): 1235–1239, 1975.
Yoshida I, Yuasa N, Horiuchi T, Tsubahara H: Effect of maternal immunity against development of Marek’s disease and protective ability of vaccine. Natl Inst Anim Health Q (Tokyo) (15): 1–7, 1975.
Spencer JL, Gavora JS, Grunder AA, Robertson A, Speckmann GW: Immunization against Marek’s disease: Influence of strain of chickens, maternal antibody, and type of vaccine. Avian Dis (18): 33–44, 1974.
Sharma JM, Graham CK: Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek’s disease vaccine. Avian Dis (26): 860–870, 1982.
Biggs PM, Shilleto RW, Milne BS: A quantitative sequential study of viraevia and neutralising antibody to HVT and MDV in a commercial flock vaccinated with HVT. Avian Pathol (9): 511–523, 1980.
King D, Page D, Schat KA, Calnek BW: Differences between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek’s disease vaccines. Avian Dis (25): 74–81, 1981.
Witter RL: Characteristics of Marek’s disease viruses isolated from vaccinated commercial chicken flocks: Association of viral pathotype with lymphoma frequency. Avian Dis (27): 113–132, 1983.
Biggs PM, Payne LN, Milne BS, Churchill AE, Chubb RC, Powell DG, Harris AH: Field trials with an attenuated cell-associated vaccine for Marek’s disease. Vet Rec (87): 704–709, 1970.
Spencer JL, Grunder AA, Robertson A, Speckmann GW: Attenuated Marek’s disease herpesvirus: protection conferred on strains of chickens varying in genetic resistance. Avian Dis (16): 94–107, 1972.
Sharma JM, Witter RL: Embryo vaccination against Marek’s disease with serotypes 1, 2 and 3 vaccines administered singly or in combination. Avian Dis (27): 453–463, 1983.
Zanella A, Valantines J, Granelli G, Castell G: Influence of strain of chickens on the immune response to vaccination against Marek’s disease. Avian Pathol (4): 247–253, 1975.
Benda V, Hlozanek I: Effect of large doses of turkey herpes virus on antibody response in chickens. Folia Biol (Praha) (21):184188, 1975.
Zander DV: Commercial applications of present alternatives for control of Marek’s disease. Avian Dis (16): 179–186, 1972.
Witter RL, Sharma JM: Polyvalent Marek’s disease vaccines — A strategy to protect chickens against challenge with very virulent Marek’s disease virus strains. Proc 18th Natl Meeting Poultry Health and Condemnations, Ocean City, MD, 1983, pp 138–148.
Good RE: Clean up of problem farms. Proc 18th Natl Meeting Poultry Health and Condemnations, Ocean City, MD, 1983, pp 54–55.
Price DJ: Use of brooding paper in relation to broiler performance. Proc 18th Natl Meeting Poultry Health and Condemnations, Ocean City, MD, 183, pp 102–103.
Witter RL, Fadly AM: Characteristics of some selected Marek’s disease virus field isolates. In: Biggs PM (ed) Resistance and Immunity to Marek’s Disease. CEC Publication EUR 6470, Luxembourg, 1980, pp 181–191.
Eidson CS, Ellis MN, Kleven SH: Reduced vaccinal protection of turkey herpesvirus against field strains of Marek’s disease herpesvirus. Poult Sci (60): 317–322, 1981.
Giambrone JJ, Eidson CS, Page RK, Fletcher QJ, Barget BO, Kleven SH: Effect of infectious bursal agent on the response of chickens to Newcastle disease and Marek’s disease vaccination. Avian Dis (20): 534–544, 1976.
Jen LW, Cho BR: Effects of infectious bursal disease on Marek’s disease vaccination: Suppression of antiviral immune response. Avian Dis (24): 896–907, 1980.
Billow V von: Immunological effects of reticuloendotheliosis virus as potential contaminant of Marek’s disease vaccines. Avian Pathol (6): 383–393, 1977.
Witter RL, Lee LF, Bacon LD, Smith EJ: Depression of vaccinal immunity to Marek’s disease by infection with reticuloendotheliosis virus. Infect Immun (26): 90–98, 1979.
Rosenberger JK: Reovirus interference with Marek’s disease vaccination. Proc Western Poult Dis Conf, Davis, CA, 1983, pp 50–51.
Landgraf H, Vielitz E, Huttner B: HVT-viraemia and protection against Marek’s disease following intramuscular or subcutaneous vaccination with different viral doses as well as following thermal stress in broiler chicks. Dtsch Tieraerztl Wochenschr (88): 524–526, 1981.
Gavora JS, Spencer JL: Breeding for immune responsiveness and disease resistance. Animal Blood Groups Biochem Genet (14):159–180, 1983.
Spencer JL, Grunder AA, Robertson A: Titres of precipitins in strains of chickens exposed to Marek’s disease. Avian Pathol (2): 17–26, 1973.
Crittenden LB: Recent advances in the genetics of disPace resistance: A review. Avian Pathol (12): 1–8, 1983.
Purchase HG: Vaccination against Marek’s disease. In: Methods for the Examination of Poultry Biologics. National Academy of Sciences National Research Council, 1971, pp 147–155.
Di Franco E, Boulay G, Filion R, Marois P: Trials of aerosol vaccination of chicks against Marek’s disease. I. Preliminary experiments. My Quebec, Dec. 51–53, 1976.
Chubis AI, Chubis ND, Safronov SV, Malygin AI, Korovin RN, Pridybailo ND: Aerosol vaccination for control of Marek’s disease in chicks. Veterinariya (Moscow) (6): 54–55, 1976.
Eidson CS, Kleven SH: Application of the cell-free turkey herpesvirus vaccine by the aerosol route for the prevention of Marek’s disease in chickens. Poult Sci (56): 1609–1615, 1977.
Marais P, Venne R, Frappier-Davignon L, Di Franco E: Trials of aerosol vaccination of chicks against Marek’s disease. II. Field trials. My Quebec, Sept. 103–106, 1979.
Eidson CS, Giambrone JJ, Fletcher OJ, Kleven SH: Vaccination against Marek’s disease with cell-free herpesvirus of turkeys by aerosol vaccination. Poult Sci (59): 54–62, 1980.
Di Franco E, Boulay G, Filion R, Marais P: Trials of aerosol vaccination of chicks against Marek’s disease. 3. Laboratory trials. My Quebec, Sept. 157–161, 1979.
Nicholas RAJ, Thornton DH, Hebert CN, Muskett JC, Evans CW: The stability of reconstituted Marek’s disease vaccines. J Biol Stand (5): 333–339, 1977.
Colwell WM, Simons DG, Harris JR, Fulp TG, Carrozza JH, Maag TA: Influence of some physical factors on survival of Marek’s disease vaccine virus. Avian Dis (19): 781–790, 1975.
Meulemans G, Bouregueil P, Halen P: Stability of freeze-dried vaccines against Marek’s disease. Ann Med Vet (119): 383–389, 1975.
Ingwersen P, Kraft V, Monreal G: Investigations about the durability of vaccines against Marek’s disease. Dtsch Tierarztl Wochenschr (81): 297–324, 1974.
Siegmann Ok, Kaleta EF, Schindler P: Short-and long-term stability studies on four lyophilized and one cell-associated turkey herpesvirus vaccines against Marek’s disease of chickens. Avian Pathol (9): 21–32, 1980.
Halvorson DA, Mitchell DO: Loss of cell-asociated Marek’s disease vaccine titer during thawing, reconstitution and use. Avian Dis (23): 848–853, 1979.
Eidson CS, Kleven SH, Anderson DP: Effect of antibiotics on turkey herpesvirus vaccine. Poult Sci (52): 755–760, 1973.
Eidson CS, Page RK, Eleven SH: In vivo and in vitro studies on the effect of gentamicin sulfate on the efficacy of the turkey herpesvirus vaccine. Poult Sci (57): 1519–1525, 1978.
Miller GP: Antibiotics in Marek’s disease vaccine. Proc 13th Natl Meeting Poultry Health and Condemnations, 1978, p 75.
Eidson CS, Villegas P, Kleven SH: Efficacy of turkey herpesvirus vaccine when administered simultaneously with fowl pox vaccine. Poult Sci (54): 1975–1981, 1975.
Eidson CS, Eleven SH: Vaccination of chickens against Marek’s disease with the herpesvirus vaccine using a pneumatic vaccinator. Poult Sci (55): 960–969, 1976.
Siccardi FJ: Research note: The addition of fowlpox and pigeon pox vaccine to Marek’s vaccine for broilers. Avian Dis (19):362–365, 1974.
Yamada S, Fujikawa H, Uchinuno Y, et al.: Canbined Marek’s disease and Newcastle disease live virus vaccine. J Jpn Vet Med Assoc (27): 493–497, 1974.
Fukikawa H: Studies on immunization against Marek’s disease: development of vaccines made of herpesvirus of turkey. III. Studies on lyophilized HVT and MD(HVT)-ND combined live virus vaccine. Bull Azabu Vet Coll (3): 137–153, 1978.
Chang JDT, Eidson CS, Dykstra MJ, Kleven SH, Fletcher 03: Vaccination against Marek’s disease and infectious bursal disease. 1. Development of a bivalent live vaccine by co-cultivating turkey and herpesvirus infectious bursal disease vaccine viruses in chicken embryo fibroblast monolayers. Poult Sci (62): 2326–2335, 1983.
Jackson CAW, Biggs PM, Bell RA, Lancaster FM, Milne BS: The epizootiology of Marek’s disease. 3. The interrelationship of virus pathogenicity, antibody and the incidence of Marek’s disease Avian Pathol (5): 105–123, 1976.
Zanella A: Marek’s disease: Survey on vaccination failures. Develop Biol Stand (52): 29–38, 1982.
Biggs PM, Jackson CAW, Bell RA, Lancaster PM, Milne BS: A vaccination study with an attenuated Marek’s disease virus. In: Biggs PM, de Thé G, Payne LN (eds) IARC Scientific Publications No 2, International Agency for Research on Cancer, Lyon, 1971, pp 139–146.
Siccardi FJ, Burmester BR: The differential diagnosis of lymphoid leukosis and Marek’s disease. U.S. Department of Agriculture Tech Bull 1412: 1–24, 1970.
Neumann U, Witter RL: Differential diagnosis of lymphoid leukosis and Marek’s disease by tumor-associated criteria. I. Studies on experimentally infected chickens. Avian Dis (23): 417–425, 1978.
Neumann U, Witter RL: Differential diagnosis of lymphoid leukosis and Marek’s disease by tumor-associated criteria. II. Studies of field cases. Avian Dis (23): 426–433, 1978.
Cauchy L, Coudert F, Dambrine G: Pathogenicity of a Marek’s disease virus for chickens vaccinated with graded doses of herpesvirus of turkeys. Avian Dis (23): 821–830, 1979.
Eidson CS, Kleven SH, Anderson DP: Vaccination against Marek’s disease with the turkey herpesvirus vaccine. Poult Sci (53): 2193–2200, 1974.
Eidson CS, Page RK, Giambrone JJ, Kleven SH: Long-term studies comparing the efficacy of cell-free versus cell-associated HVT vaccines against Marek’s disease. Poult Sci (55): 1857–1863, 1976.
Gavora JS: Vaccination against Marek’s disease: effectiveness of cell-asociated and lyophilized herpesvirus of turkeys in 9 strains of Leghorns. Poult Sci (54): 1765 1975.
Inami Y, Fojima A, Doi K, Yasoshina A, Sakma S, Okaniwa A, Takahisa Y, Takanobu M, Yoshida I: Comparative study on the effects of preventing several Marek’s disease infections with 4 types of live virus vaccines. J Jpn Vet Med Assoc (27): 20–24, 1974.
Vielitz VE, Landgraf H: The influence of homologous maternal antibodies on vaccination with turkey herpesvirus (HVT). Dtsch Tieraerztl Wochenschr (81): 177–200, 1974.
Willemart JP: Marek’s disease. Long-term results obtained with three vaccines. Rcl Med Vet (149): 349–361, 1973.
Zanella A, Granelli G: Marek’s disease control: Comparative efficacy of cell-associated and cell-free lyophilized HVT vaccine. Avian Pathol (3):45–50, 1974.
Dangschat H, Rapp W, Bengelsdorff HJ: Results of a comparative field trial using deep-frozen and lyophilized turkey herpesvirus vaccine against Marek’s disease. Berl Muench Tieraerztl Wochenschr (86): 450–453, 1973.
Kilgore RL: A comparison of the prophylactic efficacy of lyophilized and cell-associated turkey herpesviruses against Marek’s disease. Avian Dis (18): 45–49, 1974.
Guarda F, Emanuel L, Barale G, Bianchi C, Tezzo G, Monetti PG, Franchini A: Comparative trials on vaccination against Marek’s disease in broilers: Hygiene-sanitary and zootechnical aspects. Zootecnica International, Oct. 12–14, 1982.
Blaxland JD, MacLeod AJ, Hall T: Trials with Marek’s disease vaccines prepared from a turkey herpesvirus and an attenuated Marek’s disease virus. Vet Rec (97): 48–49, 1975.
Eidson CS, Villegas P, Page RK, Kleven SH: A comparison of the efficacy against Marek’s disease of cell-free and cell-associated turkey herpesvirus vaccine. Avian Dis (19): 515–524, 1975.
Picault JP, Guittet M, Bennejean G, Goater E: Prevention of Marek’s disease with the aid of 3 vaccines in chickens belonging to different genetic varieties of flesh-type reproducers. Develop Biol Stand (52): 447–454, 1982.
Eidson CS, Anderson DP, Kleven SH, Brown J: Field trials for vaccines of Marek’s disease. Avian Dis (15): 312–322, 1971.
Mustaffa-Babjee A, Spradbrow PB: Vaccination against Marek’s disease with Australian strains of turkey herpesvirus and an attenuated Marek’s disease herpesvirus. Aust Vet J (49): 347–353, 1973.
Folkers C, Stumpel MEM, Zantinga JW: The efficacy of the Marek’s disease vaccine based on strain CVI 988 (Rispens Strain). Proc 20th World Vet Cong, Thessaloniki, Greece (3): 1975, pp 2305–2306.
Goryo M, Saijo K, Takeuchi J, Taniguchi S, Obata F, Fujikawa Y: Studies on avirulent Marek’s disease virus (Strain CVI 988). I. Protective effects against chronological challenge of virulent Marek’s disease virus after the vaccination. English Summaries of the Studies on Poultry Diseases in Japan (Japanese Veterinary Poultry Association), 1979, pp 17–18.
Purchase HG, Schultz EF, Jr: The economics of Marek’s disease control in the United States. World’s Poult Sci J (34): 198–204, 1978.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Witter, R.L. (1985). Principles of Vaccination. In: Payne, L.N. (eds) Marek’s Disease. Developments in Veterinary Virology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2613-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2613-7_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9635-5
Online ISBN: 978-1-4613-2613-7
eBook Packages: Springer Book Archive